149 related articles for article (PubMed ID: 15194165)
1. A role of FcgammaRIIB in the development of collagen-induced arthritis.
Nakamura A; Takai T
Biomed Pharmacother; 2004 Jun; 58(5):292-8. PubMed ID: 15194165
[TBL] [Abstract][Full Text] [Related]
2. A shift in the balance of inhibitory and activating Fcgamma receptors on monocytes toward the inhibitory Fcgamma receptor IIb is associated with prevention of monocyte activation in rheumatoid arthritis.
Wijngaarden S; van de Winkel JG; Jacobs KM; Bijlsma JW; Lafeber FP; van Roon JA
Arthritis Rheum; 2004 Dec; 50(12):3878-87. PubMed ID: 15593228
[TBL] [Abstract][Full Text] [Related]
3. FcγRIIb on myeloid cells rather than on B cells protects from collagen-induced arthritis.
Yilmaz-Elis AS; Ramirez JM; Asmawidjaja P; van der Kaa J; Mus AM; Brem MD; Claassens JW; Breukel C; Brouwers C; Mangsbo SM; Boross P; Lubberts E; Verbeek JS
J Immunol; 2014 Jun; 192(12):5540-7. PubMed ID: 24842758
[TBL] [Abstract][Full Text] [Related]
4. Induction of arthritis by single monoclonal IgG anti-collagen type II antibodies and enhancement of arthritis in mice lacking inhibitory FcgammaRIIB.
Nandakumar KS; Andrén M; Martinsson P; Bajtner E; Hellström S; Holmdahl R; Kleinau S
Eur J Immunol; 2003 Aug; 33(8):2269-77. PubMed ID: 12884302
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of collagen-induced arthritis by human recombinant soluble FcgammaRIIb.
Magnusson SE; Andrén M; Nilsson KE; Sondermann P; Jacob U; Kleinau S
Clin Immunol; 2008 May; 127(2):225-33. PubMed ID: 18346938
[TBL] [Abstract][Full Text] [Related]
6. The inhibitory Fc gamma IIb receptor dampens TLR4-mediated immune responses and is selectively up-regulated on dendritic cells from rheumatoid arthritis patients with quiescent disease.
Wenink MH; Santegoets KC; Roelofs MF; Huijbens R; Koenen HJ; van Beek R; Joosten I; Meyer-Wentrup F; Mathsson L; Ronnelid J; Adema GJ; Bonvini E; Koenig S; van den Berg WB; van Riel PL; Radstake TR
J Immunol; 2009 Oct; 183(7):4509-20. PubMed ID: 19734236
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic control of B cell activation via recruitment of Fcgamma receptor IIb (CD32B) inhibitory function with a novel bispecific antibody scaffold.
Veri MC; Burke S; Huang L; Li H; Gorlatov S; Tuaillon N; Rainey GJ; Ciccarone V; Zhang T; Shah K; Jin L; Ning L; Minor T; Moore PA; Koenig S; Johnson S; Bonvini E
Arthritis Rheum; 2010 Jul; 62(7):1933-43. PubMed ID: 20506263
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor homolog RP105 modulates the antigen-presenting cell function and regulates the development of collagen-induced arthritis.
Tada Y; Koarada S; Morito F; Mitamura M; Inoue H; Suematsu R; Ohta A; Miyake K; Nagasawa K
Arthritis Res Ther; 2008; 10(5):R121. PubMed ID: 18847495
[TBL] [Abstract][Full Text] [Related]
9. Low-level signaling generated by FcgammaRIIB-B cell receptor co-ligation establishes a state of global B cell receptor nonresponsiveness.
Preissler MT; Kaiser L; Drake JR; Gosselin EJ
Immunol Invest; 2005; 34(1):53-70. PubMed ID: 15773572
[TBL] [Abstract][Full Text] [Related]
10. Infliximab treatment shifts the balance between stimulatory and inhibitory Fcgamma receptor type II isoforms on neutrophils in patients with rheumatoid arthritis.
Belostocki K; Pricop L; Redecha PB; Aydin A; Leff L; Harrison MJ; Salmon JE
Arthritis Rheum; 2008 Feb; 58(2):384-8. PubMed ID: 18240208
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterization.
Veri MC; Gorlatov S; Li H; Burke S; Johnson S; Stavenhagen J; Stein KE; Bonvini E; Koenig S
Immunology; 2007 Jul; 121(3):392-404. PubMed ID: 17386079
[TBL] [Abstract][Full Text] [Related]
12. IgG immune complex-binding in macrophages from arthritis-susceptible and arthritis-resistant mice following collagen type II immunization.
Thorvaldson L; Fuchs D; Magnusson S; Kleinau S
Scand J Immunol; 2006 May; 63(5):347-54. PubMed ID: 16640658
[TBL] [Abstract][Full Text] [Related]
13. Deletion of fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis.
Yuasa T; Kubo S; Yoshino T; Ujike A; Matsumura K; Ono M; Ravetch JV; Takai T
J Exp Med; 1999 Jan; 189(1):187-94. PubMed ID: 9874575
[TBL] [Abstract][Full Text] [Related]
14. Expression and function of TNF family member B cell-activating factor in the development of autoimmune arthritis.
Zhang M; Ko KH; Lam QL; Lo CK; Srivastava G; Zheng B; Lau YL; Lu L
Int Immunol; 2005 Aug; 17(8):1081-92. PubMed ID: 16000326
[TBL] [Abstract][Full Text] [Related]
15. Deregulation of peripheral B-cell development in enhanced severity of collagen-induced arthritis in FcgammaRIIB-deficient mice.
Nakamura A; Nukiwa T; Takai T
J Autoimmun; 2003 May; 20(3):227-36. PubMed ID: 12753808
[TBL] [Abstract][Full Text] [Related]
16. Fc receptors and their interaction with complement in autoimmunity.
Schmidt RE; Gessner JE
Immunol Lett; 2005 Aug; 100(1):56-67. PubMed ID: 16125792
[TBL] [Abstract][Full Text] [Related]
17. The functional variant of the inhibitory Fcgamma receptor IIb (CD32B) is associated with the rate of radiologic joint damage and dendritic cell function in rheumatoid arthritis.
Radstake TR; Franke B; Wenink MH; Nabbe KC; Coenen MJ; Welsing P; Bonvini E; Koenig S; van den Berg WB; Barrera P; van Riel PL
Arthritis Rheum; 2006 Dec; 54(12):3828-37. PubMed ID: 17133580
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mice expressing human FcgammaRIIa have enhanced sensitivity to induced autoimmune arthritis as well as elevated Th17 cells.
Van de Velde NC; Mottram PL; Powell MS; Lim B; Holmdahl R; Hogarth PM
Immunol Lett; 2010 May; 130(1-2):82-8. PubMed ID: 20005897
[TBL] [Abstract][Full Text] [Related]
19. Suppression of immune responses in collagen-induced arthritis by a rationally designed CD80-binding peptide agent.
Srinivasan M; Eri R; Zunt SL; Summerlin DJ; Brand DD; Blum JS
Arthritis Rheum; 2007 Feb; 56(2):498-508. PubMed ID: 17265485
[TBL] [Abstract][Full Text] [Related]
20. Fcgamma receptor-dependent expansion of a hyperactive monocyte subset in lupus-prone mice.
Santiago-Raber ML; Amano H; Amano E; Baudino L; Otani M; Lin Q; Nimmerjahn F; Verbeek JS; Ravetch JV; Takasaki Y; Hirose S; Izui S
Arthritis Rheum; 2009 Aug; 60(8):2408-17. PubMed ID: 19644866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
